Logo

PharmaShots Weekly Snapshots (Mar 08 - 12, 2021)

Share this

PharmaShots Weekly Snapshots (Mar 08 - 12, 2021)

PhaseBio Signs a Supply Agreement with BioVectra to Support the Development and Commercialization of Bentracimab

Published: Mar 12, 2021 | Tags: PhaseBio, Signs, Supply, Agreement, BioVectra, Support,  Development, Commercialization, Bentracimab

Takeda Reports NDA Submission of Lanadelumab to the MHLW as a Preventive Treatment for Hereditary Angioedema Attack in Japan

Published: Mar 12, 2021 | Tags: Takeda, Reports, NDA, Submission, Lanadelumab, MHLW, Preventive, Treatment, Hereditary Angioedema Attack, Japan

Sanofi and Translate Bio Initiate P-I/II Study of MRT5500 Against COVID-19

Published: Mar 12, 2021 | Tags: Sanofi and Translate Bio, Initiate, P-I/II, Study, MRT5500, Against, COVID-19

Abbott Launches Pandemic Defense Coalition to Detect Future Threats

Published: Mar 12, 2021 | Tags: Abbott, Launches, Pandemic Defense Coalition, Detect, Future, Threats

Astellas Reports NDA Submission of Enfortumab Vedotin to the MHLW for Locally Advanced or Metastatic Urothelial Cancer in Japan

Published: Mar 12, 2021 | Tags: Astellas, Reports, NDA, Submission, Enfortumab Vedotin, MHLW, Locally, Advanced, Metastatic, Urothelial Cancer, Japan

Vir and GSK Report Results of VIR-7831 in P-III COMET-ICE Trial for COVID-19

Published: Mar 12, 2021 | Tags: Vir and GSK, Report, Results, VIR-7831, P-III COMET-ICE, Trial, COVID-19

Vertex's VX-880 Receives the US FDA's Fast Track Designation for T1D

Published: Mar 11, 2021 | Tags: Vertex, VX-880, Receives, US, FDA, Fast Track Designation, T1D

Lannett Receives the US FDA's Feedback for Development of Biosimilar Insulin Glargine

Published: Mar 11, 2021 | Tags: Lannett, Receives, US, FDA, Feedback, Development, Biosimilar Insulin Glargine

Roche's Actemra/RoActemra (tocilizumab) + Veklury Fail to Meet its Primary Endpoints in P-III REMDACTA Study for Patients with Severe COVID-19 Pneumonia

Published: Mar 11, 2021 | Tags: Roche, Actemra/RoActemra (tocilizumab), Veklury, Fail, Meet, Primary Endpoints, P-III REMDACTA, Study, Patients, Severe, COVID-19, Pneumonia

Empatica's Aura System Receives European CE Mark for Detecting Early Symptoms of COVID-19 Using Wearables

Published: Mar 11, 2021 | Tags: Empatica, Aura System, Receives, European, CE Mark, Detecting, Early Symptoms, COVID-19, Wearables

Grifols Acquires Remaining 56% of GigaGen for ~$80M

Published: Mar 11, 2021 | Tags: Grifols, Acquires, Remaining, 56%, GigaGen, ~$80M

Elli Lilly Reports Results of Bamlanivimab (LY-CoV555) and Etesevimab (LY-CoV016) in P-III BLAZE-1 Study for the Prevention of COVID-19

Published: Mar 11, 2021 | Tags: Elli Lilly, Reports, Results, Bamlanivimab, Etesevimab, P-III BLAZE-1, Study, Prevention, COVID-19

Gilead Present Results of Lenacapavir in P-II/III CAPELLA Trial for the Treatment of HIV at CROI

Published: Mar 10, 2021 | Tags: Gilead, Present, Results, Lenacapavir, P-II/III CAPELLA, Trial, Treatment, HIV, CROI

SMA Foundation Collaborates with PTC to Discover and Develop Regenerative Medicine

Published: Mar 10, 2021 | Tags: SMA Foundation, Collaborates, PTC, Discover, Develop, Regenerative Medicine

Sorrento Collaborates with Mount Sinai to Develop Ab Combination for Neutralizing SARS-CoV-2 and other Emerging Variants of COVID-19

Published: Mar 10, 2021 | Tags: Sorrento, Collaborates, Mount Sinai, Develop, Ab, Combination,  Neutralizing, SARS-CoV-2, Emerging Variants, COVID-19

ViiV Healthcare Presents Results of GSK3640254 (GSK-254) in P-IIa study for the Treatment of HIV at CROI

Published: Mar 10, 2021 | Tags: ViiV Healthcare, Presents, Results, GSK3640254 (GSK’254), P-IIa study, Treatment, HIV, CROI

Novartis' Canakinumab Fails to Meet its Primary Endpoint in P-III CANOPY-2 Study

Published: Mar 10, 2021 | Tags: Novartis, Canakinumab, Fails, Meet, Primary Endpoint, P-III CANOPY-2, Study

Takeda to Acquire Maverick for ~$525M

Published: Mar 10, 2021 | Tags: Takeda, Acquire, Maverick, ~$525M

Exelixis Signs an Exclusive License Agreement with WuXi Biologics to Expand its Growing Oncology Biologics Pipeline

Published: Mar 9, 2021 | Tags: Exelixis, Signs, Exclusive, License, Agreement, WuXi Biologics, Expand, Growing, Oncology, Biologics, Pipeline

Roche's Ventana ALK (D5F3) CDx Assay Receives the US FDA's Approval for the Treatment of ALK-Positive NSCLC

Published: Mar 9, 2021 | Tags: Roche, Ventana ALK (D5F3), CDx Assay, Receives, US, FDA, Approval, Treatment, ALK-Positive NSCLC

Abbott Launches NeuroSphere Virtual Clinic for Remote Neurostim Programming in the US

Published: Mar 9, 2021 | Tags: Abbott, Launches, NeuroSphere Virtual Clinic, Remote, Neurostim Programming, US

TrinamiX Signs a Joint Development Agreement with VIAVI Solutions to Bring Near-Infrared Spectroscopy into Smartphones

Published: Mar 9, 2021 | Tags: TrinamiX, Signs, Joint Development Agreement, VIAVI Solutions,  Bring, Near-Infrared Spectroscopy, Smartphones

Lilly Collaborates with Biolojic to Discover and Develop Antibody Therapies for Diabetes

Published: Mar 9, 2021 | Tags: Lilly, Collaborates, Biolojic, Discover, Develop, Antibody, Therapies, Diabetes

Alteogen Reports Completion of P-I Study of ALT-L9 (biosimilar, aflibercept) in Korea

Published: Mar 9, 2021 | Tags: Alteogen, Reports, Completion, P-I Study, ALT-L9 (biosimilar, aflibercept), Korea

Atea Presents Results of AT-527 in P-I Study for COVID 19 at CROI

Published: Mar 8, 2021 | Tags: Atea, Presents, Results, AT-527, P-I Study, COVID 19

Kite's Yescarta Receives the US FDA's Approval for R/R Follicular Lymphoma

Published: Mar 8, 2021 | Tags: Kite, Yescarta, Receives, US, FDA, Approval, R/R Follicular Lymphoma

Gilead Presents Four-Year Data of Biktarvy for HIV-1 in Treatment-Naïve Adults at CROI 2021

Published: Mar 8, 2021 | Tags: Gilead, Presents, Four-Year Data, Biktarvy, HIV-1, Treatment, Naïve Adults

Roche to Withdraw Tecentriq Indication in Metastatic Bladder Cancer in the US

Published: Mar 8, 2021 | Tags: Roche, Withdraw, Tecentriq, Indication, Metastatic, Bladder Cancer US

Lee's Pharma to Initiate P-III Trial of Socazolimab as 1L Treatment of Extensive-stage Small-Cell Lung Cancer

Published: Mar 8, 2021 | Tags: Lee's Pharma, Initiate, P-III Trial, Socazolimab, 1L, Treatment,  Extensive-stage Small-Cell Lung Cancer

ViiV Healthcare Present Results of Long- Acting Cabotegravir and Rilpivirine in P-IIIb ATLAS-2M Study for HIV at CROI 2021

Published: Mar 8, 2021 | Tags: ViiV Healthcare, Present, Results, Long- Acting, Cabotegravir, Rilpivirine, P-IIIb ATLAS-2M, Study, HIV

Related Post: PharmaShots Weekly Snapshots (Mar 01 - 05, 2021)


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions